World's Best Scientists 2026 revealed!
Michael A. Schwarzschild

Michael A. Schwarzschild

D-Index & Metrics

Medicine

D-Index
100
Citations
32154
World Ranking
8345
National Ranking
4311

Overview

Michael A. Schwarzschild is affiliated with Harvard University in the United States. Their research primarily focuses on Medicine and Neuroscience, with significant contributions in the fields of Neurology, Molecular Biology, Cognitive Neuroscience, Cellular and Molecular Neuroscience, and Physiology.

Their work extensively covers topics related to Parkinson's Disease Mechanisms and Treatments, Autism Spectrum Disorder Research, Nuclear Receptors and Signaling, Neurological Disorders and Treatments, Neurological Diseases and Metabolism, Health Systems including Economic Evaluations and Quality of Life, and applications involving Ginkgo biloba and Cashew.

Recent publications by Schwarzschild include:

  • Incidence of Parkinson disease in North America, 2022, npj Parkinson s Disease
  • Barriers and Motivators to Engage in Exercise for Persons with Parkinson's Disease, 2020, Journal of Parkinson s Disease
  • Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression, 2021, JAMA
  • Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease, 2021, Nature Genetics
  • Disease modification and biomarker development in Parkinson disease, 2020, Neurology

Schwarzschild frequently collaborates with several researchers including Eric A. Macklin, Alberto Ascherio, Albert Y. Hung, Kjetil Bjørnevik, and Tanya Simuni.

The scientist publishes regularly in prominent venues within their research area. Their most frequent publication venues are:

  • Neurology
  • Journal of Parkinson s Disease
  • Movement Disorders
  • Parkinsonism & Related Disorders
  • bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • The epidemiology of Parkinson's disease: risk factors and prevention

    Alberto Ascherio;Alberto Ascherio;Michael A Schwarzschild

  • Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease.

    Jiang-Fan Chen;Kui Xu;Jacobus P. Petzer;Roland Staal

  • Nonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson Disease

    Honglei Chen;Shumin M. Zhang;Miguel A. Hernán;Michael A. Schwarzschild

  • Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine

    Zhi-Li Huang;Wei-Min Qu;Naomi Eguchi;Jiang-Fan Chen

  • A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice

    J.-F. Chen;Zhihong Huang;Jianya Ma;Jinmin Zhu

  • Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorylation.

    Richard E. Zigmond;M. A. Schwarzschild;A. R. Rittenhouse

  • Targeting adenosine A2A receptors in Parkinson's disease.

    Michael A. Schwarzschild;Luigi Agnati;Kjell Fuxe;Jiang-Fan Chen

  • Molecular markers of early Parkinson's disease based on gene expression in blood

    Clemens R. Scherzer;Clemens R. Scherzer;Aron C. Eklund;Lee J. Morse;Zhixiang Liao

  • Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms

    György Haskó;David G. Kuhel;Jiang Fan Chen;Michael A. Schwarzschild

  • Pesticide exposure and risk for Parkinson's disease

    Alberto Ascherio;Honglei Chen;Marc G. Weisskopf;Eilis O'Reilly

  • Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease.

    Honglei Chen;Honglei Chen;Eric Jacobs;Michael A. Schwarzschild;Marjorie L. McCullough

  • Physical activity and the risk of Parkinson disease

    H. Chen;S. M. Zhang;M. A. Schwarzschild;M. A. Hernán

  • Plasma Urate and Risk of Parkinson's Disease

    MG Weisskopf;E O'Reilly;H Chen;MA Schwarzschild

  • Urate as a predictor of the rate of clinical decline in Parkinson disease.

    Alberto Ascherio;Peter A LeWitt;Kui Xu;Shirley Eberly

  • Use of ibuprofen and risk of Parkinson disease

    Xiang Gao;Honglei Chen;Michael A. Schwarzschild;Alberto Ascherio

  • Novel pharmacological targets for the treatment of Parkinson's disease

    Anthony H V Schapira;Erwan Bezard;Jonathan Brotchie;Frédéric Calon

  • Habitual intake of dietary flavonoids and risk of Parkinson disease

    X. Gao;A. Cassidy;M.A. Schwarzschild;E.B. Rimm

  • Peripheral Inflammatory Biomarkers and Risk of Parkinson's Disease

    Honglei Chen;Eilis J. O'Reilly;Michael A. Schwarzschild;Alberto Ascherio;Alberto Ascherio

  • Prospective study of dietary pattern and risk of Parkinson disease

    Xiang Gao;Honglei Chen;Teresa T Fung;Teresa T Fung;Giancarlo Logroscino

  • Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson Disease

    Michael A. Schwarzschild;Steven R. Schwid;Kenneth Marek;Arthur Watts

Frequent Co-Authors

Alberto Ascherio
Alberto Ascherio Harvard University
Honglei Chen
Honglei Chen Michigan State University
Jiang-Fan Chen
Jiang-Fan Chen Boston University
Marjorie L. McCullough
Marjorie L. McCullough American Cancer Society
Caroline M. Tanner
Caroline M. Tanner University of California, San Francisco
Anthony E. Lang
Anthony E. Lang University of Toronto
Joseph J. Locascio
Joseph J. Locascio Harvard University
David G. Standaert
David G. Standaert University of Alabama at Birmingham
Rosario Moratalla
Rosario Moratalla Spanish National Research Council
Bradley T. Hyman
Bradley T. Hyman Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare careers beyond traditional medical school, a wide range of online healthcare administration programs offer flexible options to launch or advance your career. These programs are ideal for students seeking roles in hospital management, policy, or healthcare operations.

A popular next step for leadership roles is the Master of Healthcare Administration (MHA). However, prospective students should carefully consider mha degree cost to ensure affordability while securing a reputable degree.

For those pursuing clinical leadership, nursing, or advanced practice, the best dnp programs online provide a path to the highest credential in nursing practice. Similarly, pharmacists seeking advanced roles can explore accredited online pharmacist programs designed for flexibility and career growth.

With the growing popularity of online healthcare degrees, students have more options than ever to balance their studies with work or personal commitments while preparing for rewarding careers in healthcare.

Best Scientists Citing Michael A. Schwarzschild

Trending Scientists